 |
 |
Search
- Page Path
-
- HOME
- Search
- Enhancing Quality of Life in Multiple Sclerosis Patients Through Coadministration of FDA-Approved Immunomodulators and Melatonin
- Cenk Serhan Ozverel, Emine Erdag
- Chronobiol Med. 2024;6(3):135-142. Published online September 30, 2024
- Editorial Office
-
RN1611, 725, Suseo-Dong, Gangnam-Gu, Seoul 06367, Republic of Korea
Tel: +82-2-445-1611 Fax: +82-2-445-1633 E-mail: editor@chronobiologyinmedicine.org
Copyright © 2024 by Korean Academy of Sleep Medicine. All rights reserved.
